Colorectal Carcinoma (CRC)
8
2
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
1 terminated out of 8 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer
Pilot Window of Opportunity Trial (POET)
Perioperative Blood Adiponectin Dynamics and Systemic Infflamatory Response After Major Colorectal Surgery
The Intraoperative Technical Errors of Robotic vs. Laparoscopic Radical Right Hemiclectomy
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Patient-led Follow-up from Home After Surgery for Colorectal Carcinoma
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies